Moleculin Biotech, Inc. — Director's Dealing 2016

Aug 23, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moleculin Biotech, Inc. (MBRX)
CIK: 0001659617
Period of Report: 2016-08-19

Reporting Person: Foster Jonathan P. (Exec. Vice President & CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-19	Option to purchase common stock	$5.85	A	400000	Acquired	2026-08-19	Common Stock (400000)	Direct

Footnotes

F1: The options set forth in this table vest in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service as the Company's Chief Financial Officer.

F2: The options were issued in connection with the reporting person's employment service to the Company.